Emerging indications for permanent pacing

Current Cardiology Reports

Volumn 2, Issue 4, 2000, Pages 353-360

  Wolbrette, Deborah L ^a   Naccarelli, Gerald V ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; HEART ATRIUM FIBRILLATION; HEART PACING; HEMODYNAMICS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; METHODOLOGY; PATHOPHYSIOLOGY; REVIEW; SYNCOPE; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; SYNCOPE, VASOVAGAL; TREATMENT OUTCOME;

EID: 0034220036     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-000-0093-3     Document Type: Article

References (43)

1. Sutton R, Petersen M, Brignole M, et al. : Proposed classification for tilt-induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 1992, 2:180-183.
2. Fitzpatrick AP, Travill CM, Vardas PE, et al. : Recurrent symptoms after ventricular pacing in unexplained syncope. PACE 1990, 13:619-624.
3. Samoil D, Grubb BP, Brewster P, et al. : Comparison of single and dual chamber pacing techniques in prevention of upright induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 1993, 1:36-41.
4. Petersen MEV, Chamberlain-Webber R, Fitzpatrick AP, et al. : Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J 1994, 71:274-281.
5. Ammirati F, Colivicchi F, Toscano S, et al. : DDD pacing with rate drop response function versus DDI with rate hysteresis pacing for cardioinhibitory vasovagal syncope. PACE 1998, 21(II):2178-2181.
6. Benditt DG, Sutton R, Gammage MD, et al. : and the International Rate-Drop Investigators Group: Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. PACE 1997, 20:832-839.
7. Sheldon R, Koshman ML, Wilson W, et al. : Effect of dualchamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope. Am J Cardiol 1998, 81:158-162.
8. Connolly SJ, Sheldon R, Roberts RS, Gent M: The North American vasovagal Pacemaker Study (VPS): a randomized trail of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999, 33:16-20.
9. Benditt DG: Cardiac pacing for prevention of vasovagal syncope-editorial comment. J Am Coll Cardiol 1999, 33:21-23.
10. Shah CP, Thakur RK, Xie B, Pathak P: Dual chamber pacing for neurally mediated syncope with a prominent cardioinhibitory component. PACE 1999, 22:999-1003.
11. Benditt DG, Sutton R, Gammage M, et al. : "Rate-drop response" cardiac pacing for vasovagal syncope. Rate-drop response investigators group. J Interv Card Electrophysiol 1999, 3:27-33.
12. Mitton CR, Rose MS, Koshman ML, Sheldon RS: Cost-utility analysis of pacemakers for the treatment of vasovagal syncope. Am J Cardiol 1999, 84:1356-1359.
13. Gregoratos G, Cheitlin MD, Conill A, et al. : ACC/AHA Guidelines for implantation of cardiac pacemakers and arrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998, 31:1175-1209.
14. Jeanrenaud X, Goy JJ, Kappenberger L: Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 1992, 339:1318-1323.
15. Fananapazir L, Cannon RO III, Tripodi D, Panza JA: Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and B-adrenergic blocker therapy. Circulation 1992, 85:2149-2161.
16. Fananapazir L, Epstein ND, Curiel RV, et al. : Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994, 90:2731-2742.
17. Nishimura RA, Trusty JM, Hayes DL, et al. : Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol 1997, 29:435-441.
18. Kappenberger L, Linde C, Daubert C, et al. : and the PIC Study Group: Pacing in hypertrophic obstructive cardiomyopathy: a randomized crossover study. Eur Heart J 1997, 18:1249-1256.
19. Maron BJ, Nishimura RA, McKenna WJ, et al. : for the M-PATHY Study Investigators: Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: a randomized, double-blind crossover study (MPATHY). Circulation 1999, 99:2927-2933.
20. O'Rourke RA: Cardiac pacing: an alternative treatment for selected patients with hypertrophic cardiomyopathy and adjunctive therapy for certain patients with dilated cardiomyopathy. Circulation 1999, 100:786-788.
21. Gadler F, Linde C, Darpo B: Rapid return of left ventricular outflow tract obstruction and symptoms following cessation of longterm atrioventricular synchronous pacing for obstructive hypertrophic cardiomyopathy. Eur Heart J 1998, 19:132-138.
22. Ommen SR, Nishimura RA, Squires RW, et al. : Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1999, 34:191-196.
23. Seggewiss H, Gleichmann U, Faber L, et al. : Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998, 31:252-258.
24. Lakkis NM, Nagueh SF, Kleiman NS, et al. : Echocardiographyguided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 1998, 98:1750-1755.
25. Cleland JGF, Clark A: Has the survival of the heart failure population changed? Lessons from trials. Am J Cardiol 1999, 83:112D-119D.
26. Hochleitner M, Hortnagl H, Ng CK, et al. : Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol 1990, 66:198-202.
27. Auricchio A, Sommariva L, Sabo RW, et al. : Improvement of cardiac function in patients with severe congestive heart failure and coronary artery disease by dual chamber pacing with shortened AV delay. Pacing Clin Electrophysiol 1993, 16:2034-2043.
28. Kusumoto FM, Goldschlager N: Cardiac pacing in patients with dilated cardiomyopathy. J Interv Card Electrophysiol 1997, 1:103-110.
29. Linde C, Gadler F, Edner M, et al. : Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. Am J Cardiol 1995, 75:919-923.
30. Gold MR, Feliciano Z, Gottleib SS, Fischer ML: Dual-chamber pacing with short atrioventricular delay in congestive heart failure: a randomized study. J Am Coll Cardiol 1995, 26:967-973.
31. Innes D, Leitch JW, Fletcher PJ: VDD pacing at short atrioventricular intervals does not improve cardiac output in patients with dilated heart failure. PACE 1994, 17:959-965.
32. Nishimura RA, Hayes DL, Holmes DR, Tajik AJ: Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute Doppler and catheterization hemodynamic study. J Am Coll Cardiol 1995, 25:281-288.
33. Paul V, Cowell R, Thurgood-Morris J, Jepson N: First degree heart block in heart failure: is this a class one indication for dual chamber pacing [abstract]? PACE 1995, 18(II):906.
34. Auricchio A, Stellbrink C, Sack S, et al. : for the PATH-CHF Study Group: The Pacing Therapies for Congestive Heart Failure (PATH-CHF) Study: rationale, design, and endpoints of a prospective randomized multicenter study. Am J Cardiol 1999, 83:130D-135D.
35. Auricchio A, Stellbrink C, Block M, et al., for the Pacing Therapies for Congestive Heart Failure Study Group; and Kramer A, Ding J, Sabo R, et al., for the Guidant Congestive Heart Failure Research Group: Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 1999, 99:2993-3001.
36. Saxon LA, Boehmer JP, Hummel J, et al., for the VIGOR-CHF and VENTAK-CHF investigators: Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. Am J Cardiol 1999, 83:120D-123D.
37. Saxon LA, DeMarco T, Chatterjee K, Boehmer J, for the VIGORCHF Investigators: The magnitude of sympathoneural activation in advanced heart failure is altered with chronic biventricular pacing [abstract]. PACE 1998, 21:914.
38. Kass DA, Chen CH, Curry C, et al. : Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999, 99:1567-1573.
39. Etienne Y, Mansourati J, Gilard M, et al. : Evaluation of left ventricular based pacing in patients with congestive heart failure and atrial fibrillation. Am J Cardiol 1999, 83:1138-1140.
40. Auricchio A, Klein H, Tockman B, et al. : Transvensus biventricular pacing for heart failure: can the obstacles be overcome? Am J Cardiol 1999, 83:136D-142D.
41. Gras D, Mabo P, Tang T, et al. : Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. In Sync Study. PACE 1998, 21(II):2249-2255.
42. Delfaut P, Saksena S, Prakash A, Krol RB: Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single-and dual-site right atrial pacing for arrhythmia prevention. J Am Coll Cardiol 1998, 32:1900-1908.
43. Misier ARR, Beukema WP, Luttikhuis HAO: Multisite or alternate site pacing for the prevention of atrial fibrillation. Am J Cardiol 1999, 83:237D-240D.